Marbofloxacin

Product Name: Marbofloxacin
Synonyms of Marbofloxacin (CAS NO.115550-35-1): Marbofloxacin [INN] ; 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid ; CCRIS 8212 ; Marbofloxacine ; Marbofloxacine [INN-French] ; Marbofloxacino ; Marbofloxacino [INN-Spanish] ; Marbofloxacinum ; Marbofloxacinum [INN-Latin] ; UNII-8X09WU898T ; 7H-Pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
CAS NO: 115550-35-1
Classification Code: Drug / Therapeutic Agent ; Enzyme inhibitors
Molecular Formula: C₁₇H₁₉FN₄O₄
Molecular Weight: 362.3556
Molecular Structure:

Melting Point: 268-269°C
Polar Surface Area: 65.56 Å²
Index of Refraction: 1.701
Molar Refractivity: 90.37 cm³
Molar Volume: 233.5 cm³
Surface Tension: 78.3 dyne/cm
Density: 1.55 g/cm³
Flash Point: 298.8 °C
Enthalpy of Vaporization: 90.02 kJ/mol
Boiling Point: 570.5 °C at 760 mmHg
Vapour Pressure: 7.45E-14 mmHg at 25°C

 Marbofloxacin (CAS NO.115550-35-1) is used in veterinary medicine under the trade names Marbocyl and Zeniquin. It can be used both orally and topically. Marbofloxacin (CAS NO.115550-35-1) is particularly used for infections of the skin, respiratory system and mammary glands, as well as with urinary tract infections in dogs.

Hazard Codes: Xi
Risk Statements: 52/53-36/37/38 
R52/53: Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. 
R36/37/38: Irritating to eyes, respiratory system and skin.
Safety Statements: 61-36-26 
S61: Avoid release to the environment. Refer to special instructions / safety data sheets. 
S36: Wear suitable protective clothing. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RTECS: UU8815140

 Mechanism of action: Marbofloxacin (CAS NO.115550-35-1) is a quinolone, and acts by inhibiting bacterial DNA replication.